Ryurei
Catheters, Transluminal Coronary Angioplasty, Percutaneous. 510(k) K252295, from Terumo Corporation (Tokyo, JP). Product code LOX, class 2.
As of Nov 19, 2026, K252295 is an FDA 510(k) held by Terumo Corporation, substantially equivalent on Mar 27, 2026 after 247 days, with no recalls tied to it in FDA's recall database.
- Review time: 247 days
- Recalls: 0
Ryurei (1.5 mm) is indicated for: • Balloon dilatation of the stenotic portion of a coronary artery or bypass graft stenosis in patients evidencing coronary ischemia for the purpose of improving myocardial perfusion. • Balloon dilatation of a coronary artery occlusion for the treatment of acute myocardial infarction.
- Sapphire II PRO Balloon Dilatation CatheterK180921 · Orbusneich Medical Trading, Inc. · Jun 28, 2018
- NC Euphora Rapid Exchange Balloon Dilatation CatheterK261428 · Medtronic Ireland · Aug 14, 2026
- Euphora Rapid Exchange (RX) Balloon Dilatation CatheterK261759 · Medtronic Ireland · Jul 27, 2026
- Firefighter™ Pro PTCA Balloon CatheterK252116 · Shanghai MicroPort Medical (Group) Co., Ltd. · Apr 7, 2026
- FLASH Flex™ Aorto-Ostial Angioplasty SystemK254022 · Verge Medical, Inc. · Apr 2, 2026
- Sprinter Legend Rapid Exchange Balloon Dilatation CatheterK251970 · Medtronic, Ireland · Jan 17, 2026
- Pantera Pro; Pantera LEOK242969 · Biotronik, Inc. · Oct 25, 2024
- Sapphire NC ULTRA Coronary Dilatation CatheterK233499 · OrbusNeich Medical (Shenzhen) Co., Ltd. · Aug 16, 2024
- Sapphire ULTRA Coronary Dilatation CatheterK233505 · OrbusNeich Medical (Shenzhen) Co., Ltd. · Aug 15, 2024
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Jul 23, 2025
- Review panel
- Cardiovascular
- Regulation
- 21 CFR 870.5100
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files